SEI Investments’s Oncolytics Biotech ONCY Stock Holding History

SEI Investments’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-774	Closed	-$4K	–	3145
2018 Q2	$4K	Buy	+774	New	+$4.76K	﹤0.01%	3210

Other funds holding ONCY

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

SEI Investments's ONCY Position: Q3 2018 in Review

SEI Investments sold out of Oncolytics Biotech (ONCY) in Q3 2018, closing a stake of 774 shares — an estimated $4K sold.

SEI Investments first reported a position in ONCY in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 21 funds tracked by Wall St. Rank hold ONCY as of Q3 2018.

SEI Investments reported no remaining Oncolytics Biotech position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 774 Oncolytics Biotech shares in Q3 2018, an estimated $4K.
SEI Investments first reported a position in Oncolytics Biotech in Q2 2018 and held it in 1 quarter.
SEI Investments's Oncolytics Biotech position peaked at $4K in Q2 2018.
21 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.